ENDRA Life Sciences Inc.

NASDAQ: NDRA · Real-Time Price · USD
4.48
0.04 (0.90%)
At close: Aug 15, 2025, 9:50 AM

ENDRA Life Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
3.23M 2.83M 4.89M 9.46M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
371.4K 3.26M 5.99K 5.99K
Receivables
n/a n/a n/a -1.35M
Inventory
n/a n/a 2.64M 1.28M
Other Current Assets
n/a n/a n/a 1.35M
Total Current Assets
3.43M 3.03M 8.53M 12.09M
Property-Plant & Equipment
647.29K 465.87K 741.47K 774.54K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.02M 3.72M 747.46K 780.53K
Total Assets
4.45M 6.75M 9.27M 12.87M
Account Payables
269.68K 360.4K 613.96K 791.05K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
96.94K 28.48K 28.48K 132.33K
Other Current Liabilities
169.72K 148.79K 158.93K 269.46K
Total Current Liabilities
605.23K 903.1K 1.7M 1.54M
Long-Term Debt
487.48K n/a n/a 28.48K
Other Long-Term Liabilities
799.28K n/a n/a n/a
Total Long-Term Liabilities
1.29M 192.06K 365.92K 546.63K
Total Liabilities
1.89M 1.1M 2.07M 2.09M
Total Debt
584.42K 394.4K 546.63K 678.96K
Common Stock
53.00 1.04K 317.00 4.25K
Retained Earnings
-103.44M -91.93M -81.87M -68.69M
Comprehensive Income
n/a 5.23K 6.07K 13.86K
Shareholders Equity
2.56M 5.66M 7.2M 10.78M
Total Investments
n/a n/a n/a n/a